蒲公英30指数
Search documents
Wind ESG高级分析师翁钰宁:华夏—Wind ESG蒲公英指数引领医疗健康行业可持续发展|聚焦2025华夏大健康
Hua Xia Shi Bao· 2025-11-22 14:32
Core Viewpoint - The 2025 Huaxia Health Industry Development and Rehabilitation Service Conference emphasizes the importance of technology and innovation in the healthcare sector, alongside the growing focus on environmental, social, and governance (ESG) performance of healthcare companies [2][3]. Group 1: ESG Rating System - The Dandelion Index, developed by Huaxia Times Health Research Institute and Wind, selects the top 50 companies from 495 A-share healthcare companies and 30 from 262 Hong Kong healthcare companies, adjusting the components monthly based on ESG scores [3][4]. - The ESG rating system evaluates companies on long-term management practices across environmental, social, and governance dimensions, incorporating over 500 indicators and 28 topics, with a focus on industry-specific issues [4][7]. Group 2: Index Performance - The Dandelion Index shows superior performance, with the Dandelion 50 Index rising approximately 29% year-to-date, outperforming the CSI 300 and healthcare industry indices by about 35 percentage points, with an annualized return of around 10% [8][11]. - The Dandelion 30 Index has achieved a year-to-date increase of 104%, significantly surpassing the Hong Kong healthcare industry index and the Hang Seng Index, with a five-year cumulative return of 63% [11][12]. Group 3: Company Ratings - 80 companies with excellent ESG performance are included in the Dandelion Index, with Haier Biomedical and Yinkang Life receiving the highest AAA rating [7]. - In the Dandelion 50 Index, 62% of companies are rated AA, while 34% are rated A; the Dandelion 30 Index has 77% rated AA, with no low-rated companies, contrasting with over 69% of the healthcare industry having low ratings [7][8]. Group 4: Call to Action - The conference encourages more companies to engage in ESG practices and register on the Wind ESG issuer communication platform for rating feedback, aiming to promote sustainable development in the industry [14].